Price to Book Value Chart

View Price to Book Value for EVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2021. Start Trial.
Date Value
September 11, 2026 2.739
September 10, 2026 2.713
September 09, 2026 2.879
September 08, 2026 2.774
September 04, 2026 2.730
September 03, 2026 2.695
September 02, 2026 2.686
September 01, 2026 2.608
August 31, 2026 2.625
August 28, 2026 2.634
August 27, 2026 2.756
August 26, 2026 2.835
August 25, 2026 2.932
August 24, 2026 2.975
August 21, 2026 2.896
August 20, 2026 2.870
August 19, 2026 2.756
August 18, 2026 2.756
August 17, 2026 2.739
August 14, 2026 2.923
August 13, 2026 2.810
August 12, 2026 2.686
August 11, 2026 2.678
August 10, 2026 2.669
August 07, 2026 2.713
Date Value
August 06, 2026 2.621
August 05, 2026 2.608
August 04, 2026 2.582
August 03, 2026 2.441
July 31, 2026 2.468
July 30, 2026 2.476
July 29, 2026 2.485
July 28, 2026 2.450
July 27, 2026 2.529
July 24, 2026 2.590
July 23, 2026 2.669
July 22, 2026 2.660
July 21, 2026 2.643
July 20, 2026 2.573
July 17, 2026 2.691
July 16, 2026 2.730
July 15, 2026 2.669
July 14, 2026 2.652
July 13, 2026 2.643
July 10, 2026 2.774
July 09, 2026 2.800
July 08, 2026 2.844
July 07, 2026 2.896
July 06, 2026 2.958
July 02, 2026 2.984

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Autolus Therapeutics Plc 8.920
DBV Technologies SA 3.373
Cellectis SA 7.601
Akari Therapeutics Plc 1.064
Ascendis Pharma A/S 10.54

Price to Book Value Related Metrics

PS Ratio 3.112
Price 3.13
Earnings Yield -33.66%
Market Cap 26.10M